DC
Therapeutic Areas
Indian Immunologicals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Abhayrab | Human Rabies | Approved |
| Hepatitis A Vaccine | Human Hepatitis A | Approved |
| Porcine Cysticercosis Vaccine | Porcine Cysticercosis | Approved |
| gE‑Deleted DIVA Marker Vaccine | Infectious Bovine Rhinotritis (IBR) | Approved |
| Bi‑valent Human Monoclonal Antibody for Rabies | Human Rabies Post‑Exposure Prophylaxis | Phase 1 |